brca3 | 59563

Genetics Carriership of a familial variant

Keywords

ATM, BARD1, BRCA1, BRCA2, breast and ovarian cancer, BRIP1, carriership of a pathogenic familial variant, CDH1, CDKN2A, CHEK2, endometrial cancer, EPCAM, HBOC, Hereditary cancer, HNPCC, HOXB13, Lynch syndrome, MLH1, MSH2, MSH6, PALB2, pancreatic cancer, PMS2, prostate cancer, PTEN, RAD51C, RAD51D, STK11, TP53

Material
Blood EDTA
EDTA tube, purple (6)
Note

Search for mutations or gene dosage changes known in the family, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, PALB2, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53. | Preliminary findings of a known mutation or gene dosage change in the family are required for the analysis to be carried out. | Declaration of consent for genetic examination in accordance with GUMG required (see OF Human genetics or www.viollier.ch/en/SGMG_consent) | There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order.

Min. quantity 4 mL
Stability 1 week / 2-8°C
Duration 3 weeks
Frequency 1 x per month
Method Next Generation Sequencing
Price CHF 338.40
Tariff 338.40 TP

Team of consultants

PhD Christoph Noppen FAMH Specialist in laboratory medicine, medical genetics
FAMH Specialist in laboratory medicine, medical genetics T +41 61 486 14 79
DSc Henriette Kurth FAMH Specialist in laboratory medicine, medical genetics
FAMH Specialist in laboratory medicine, medical genetics T +41 61 486 14 78
Dr. sc. nat. Andrea Salzmann Candidate FAMH Specialist in laboratory medicine, main field medical genetics
Candidate FAMH Specialist in laboratory medicine, main field medical genetics T +41 61 486 14 80